About EIHSX
Eaton Vance Worldwide Health Sciences Fund Class I is an actively managed mutual fund focused on achieving long-term capital growth by investing in health sciences companies worldwide. The fund primarily targets firms involved in the discovery, development, production, or distribution of healthcare-related products and services, including biotechnology, pharmaceuticals, diagnostics, medical equipment and supplies, and managed healthcare. The investment approach emphasizes a diversified, global portfolio, selecting stocks that are considered reasonably valued with strong growth potential, regardless of short-term market movements. This strategy is supported by a team based in Boston and London. The fund benefits from sector tailwinds such as aging demographics, ongoing innovation, and rising global incomes, all contributing to increasing healthcare demand. With a minimum investment threshold set for institutional investors, this class aims to provide exposure across developed and emerging healthcare markets, balancing large-cap leaders with emerging innovators. Eaton Vance Worldwide Health Sciences Fund Class I plays a pivotal role for investors seeking diversified access to global healthcare growth opportunities while navigating sector-specific risks such as regulatory changes, market volatility, and technological advancements.
Fund Family Eaton Vance
Category Health
Stock Exchange NASDAQ
Ticker Symbol EIHSX
Share Class Class I
Index MSCI World/Health Care NR
EIHSX had a total return of -7.45% in the past year, including dividends. Since the fund's
inception, the average annual return has been 11.34%.
